Loading video...

Video Failed to Load

There was a problem loading this video. This could be due to a temporary network issue or the video might be unavailable.

AEI’s Scott Gottlieb, MD 🇺🇸 joined Squawk Box to walk through possible updates to childhood vaccine schedules and discuss the new drug pricing proposals from the White House.

American Enterprise Institute

168,418 subscribers

64,448 views • 7 months ago •via X (Twitter)

Health & Wellness News & Politics

Anya Rossi• Live Now

Private livecam show

0 Comments

No comments available

Comments from the original post will appear here

Related Videos

AEI’s Scott Gottlieb, MD 🇺🇸 joined CBS’ Face the Nation to break down the latest updates to the CDC’s pediatric vaccine schedule.

AEI’s Scott Gottlieb, MD 🇺🇸 joined CBS’ Face the Nation to break down the latest updates to the CDC’s pediatric vaccine schedule.

American Enterprise Institute

52,157 views • 8 months ago

AEI’s Scott Gottlieb, MD 🇺🇸 joins CNBC’s Squawk Box to discuss why the FDA’s new rare disease framework is an encouraging first step and how FDA can build on the guidance to create a path for the clinical development of new therapies.

AEI’s Scott Gottlieb, MD 🇺🇸 joins CNBC’s Squawk Box to discuss why the FDA’s new rare disease framework is an encouraging first step and how FDA can build on the guidance to create a path for the clinical development of new therapies.

American Enterprise Institute

13,254 views • 4 months ago

AEI Senior Fellow Scott Gottlieb, MD 🇺🇸 joins CNBC’s Squawk Box to discuss the FDA’s new efforts to improve competitiveness with China, new leadership, and where the agency is headed.

AEI Senior Fellow Scott Gottlieb, MD 🇺🇸 joins CNBC’s Squawk Box to discuss the FDA’s new efforts to improve competitiveness with China, new leadership, and where the agency is headed.

American Enterprise Institute

60,804 views • 1 month ago

AEI Senior Fellow Scott Gottlieb, MD 🇺🇸 joins CNBC’s Squawk Box to discuss concerns over the shift of drug trials to China and the FDA’s new PreCheck program aimed at bringing pharmaceutical manufacturing back to U.S. soil.

AEI Senior Fellow Scott Gottlieb, MD 🇺🇸 joins CNBC’s Squawk Box to discuss concerns over the shift of drug trials to China and the FDA’s new PreCheck program aimed at bringing pharmaceutical manufacturing back to U.S. soil.

American Enterprise Institute

34,197 views • 1 month ago

AEI senior fellow Scott Gottlieb, MD 🇺🇸 joins CNBC’s Squawk Box to discuss the latest developments in the Ebola outbreak in West Africa and FDA management changes.

AEI senior fellow Scott Gottlieb, MD 🇺🇸 joins CNBC’s Squawk Box to discuss the latest developments in the Ebola outbreak in West Africa and FDA management changes.

American Enterprise Institute

116,341 views • 2 months ago

AEI’s Scott Gottlieb, MD 🇺🇸 breaks down the FDA’s approach to infant formula safety and food ingredients.

AEI’s Scott Gottlieb, MD 🇺🇸 breaks down the FDA’s approach to infant formula safety and food ingredients.

American Enterprise Institute

40,838 views • 5 months ago

AEI’s Scott Gottlieb, MD 🇺🇸 joined CNBC to discuss his op-ed in the Washington Post on how Chinese biotech is copying American breakthroughs—and how the FDA can respond by reducing development costs for U.S. innovators.

AEI’s Scott Gottlieb, MD 🇺🇸 joined CNBC to discuss his op-ed in the Washington Post on how Chinese biotech is copying American breakthroughs—and how the FDA can respond by reducing development costs for U.S. innovators.

American Enterprise Institute

13,808 views • 10 months ago

AEI’s Scott Gottlieb, MD 🇺🇸 joined CNBC to weigh in on reports that the Trump Administration may approve a new indication for folinic acid, a metabolically active form of folate, to treat the symptoms of autism.

AEI’s Scott Gottlieb, MD 🇺🇸 joined CNBC to weigh in on reports that the Trump Administration may approve a new indication for folinic acid, a metabolically active form of folate, to treat the symptoms of autism.

American Enterprise Institute

43,630 views • 10 months ago

AEI senior fellow Scott Gottlieb, MD 🇺🇸 joins Squawk Box to break down the latest on the hantavirus, developments at the FDA, and the agency’s updated policies on vaping devices.

AEI senior fellow Scott Gottlieb, MD 🇺🇸 joins Squawk Box to break down the latest on the hantavirus, developments at the FDA, and the agency’s updated policies on vaping devices.

American Enterprise Institute

40,680 views • 3 months ago

AEI’s Scott Gottlieb, MD 🇺🇸 breaks down the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments.

AEI’s Scott Gottlieb, MD 🇺🇸 breaks down the rapid expansion of CAR-T therapies, the implications of the new Psychedelics Executive Order, and efforts to streamline FDA approvals for next-gen treatments.

American Enterprise Institute

21,956 views • 3 months ago

.Scott Gottlieb, MD 🇺🇸 discusses the FDA's PreCheck Pilot Program aimed at accelerating new drug pipelines:

.Scott Gottlieb, MD 🇺🇸 discusses the FDA's PreCheck Pilot Program aimed at accelerating new drug pipelines:

Squawk Box

122,045 views • 1 month ago

AEI's Scott Gottlieb, MD 🇺🇸: the US should be taking more steps to mitigate the possible spread of bird flu.

AEI's Scott Gottlieb, MD 🇺🇸: the US should be taking more steps to mitigate the possible spread of bird flu.

American Enterprise Institute

19,571 views • 1 year ago

Here is an excellent interview of Dr. Scott Gottlieb, MD 🇺🇸 - the former FDA commissioner on Squawk Box, in which Dr. Gottlieb wonderfully explains the root causes which have led BioTech and big Pharma companies to shift drug discovery to China, the threat that the Chinese BioTech ecosystem poses to the U.S. one 🧵👇and what policy steps are needed in order to level the playing field for early drug discovery. Excellent conversation which is definitely worth listening to! $XBI

Here is an excellent interview of Dr. Scott Gottlieb, MD 🇺🇸 - the former FDA commissioner on Squawk Box, in which Dr. Gottlieb wonderfully explains the root causes which have led BioTech and big Pharma companies to shift drug discovery to China, the threat that the Chinese BioTech ecosystem poses to the U.S. one 🧵👇and what policy steps are needed in order to level the playing field for early drug discovery. Excellent conversation which is definitely worth listening to! $XBI

Yair Einhorn

59,753 views • 10 months ago

Over the weekend, AEI senior fellow and former FDA commissioner Scott Gottlieb, MD 🇺🇸 joined CBS News’ Face the Nation to discuss the federal response to the cyclospora outbreak, rising measles cases amid declining vaccination rates, and the risks of compounded peptides.

Over the weekend, AEI senior fellow and former FDA commissioner Scott Gottlieb, MD 🇺🇸 joined CBS News’ Face the Nation to discuss the federal response to the cyclospora outbreak, rising measles cases amid declining vaccination rates, and the risks of compounded peptides.

AEI Economics

18,162 views • 19 days ago

.Scott Gottlieb, MD 🇺🇸 discusses the latest developments in the cyclospora outbreak & risks to the public:

.Scott Gottlieb, MD 🇺🇸 discusses the latest developments in the cyclospora outbreak & risks to the public:

Squawk Box

89,741 views • 25 days ago

🚩 Last week Pfizer board member Scott Gottlieb, MD 🇺🇸 attacked Robert F. Kennedy Jr on Squawk Box while claiming “we [Pfizer] don’t make the pediatric vaccines. Pfizer is not in that market.” Scott fails to mention that the PREVNAR vaccine, which is FDA approved & CDC recommended for adults AND children, is one of Pfizer's top products grossing nearly $5 Billion in sales already in 2024. Why didn't Scott disclose this conflict of interest?

🚩 Last week Pfizer board member Scott Gottlieb, MD 🇺🇸 attacked Robert F. Kennedy Jr on Squawk Box while claiming “we [Pfizer] don’t make the pediatric vaccines. Pfizer is not in that market.” Scott fails to mention that the PREVNAR vaccine, which is FDA approved & CDC recommended for adults AND children, is one of Pfizer's top products grossing nearly $5 Billion in sales already in 2024. Why didn't Scott disclose this conflict of interest?

Chief Nerd

47,982 views • 1 year ago

AEI's Scott Gottlieb, MD 🇺🇸: The best step we can take to combat bird flu is through improved biosecurity on farms, which Secretary Rollins has proposed.

AEI's Scott Gottlieb, MD 🇺🇸: The best step we can take to combat bird flu is through improved biosecurity on farms, which Secretary Rollins has proposed.

American Enterprise Institute

49,381 views • 1 year ago

I joined Squawk Box this morning to discuss: - Bitcoin ETF - The SEC - Stablecoins - American entrepreneurship - The beauty of our judicial system - Why yelling at regulators is unproductive Here is the full segment with Scott Wapner and Melissa Lee

I joined Squawk Box this morning to discuss: - Bitcoin ETF - The SEC - Stablecoins - American entrepreneurship - The beauty of our judicial system - Why yelling at regulators is unproductive Here is the full segment with Scott Wapner and Melissa Lee

Anthony Pompliano 🌪

94,964 views • 2 years ago

.Adam Back joined Squawk Box to weigh in on the recent The New York Times Satoshi Nakamoto article.

.Adam Back joined Squawk Box to weigh in on the recent The New York Times Satoshi Nakamoto article.

Blockstream

54,537 views • 4 months ago

I joined Squawk Box to discuss what the market structure principles mean for clear & innovative digital asset legislation. Listen now. ⬇️

I joined Squawk Box to discuss what the market structure principles mean for clear & innovative digital asset legislation. Listen now. ⬇️

Senator Cynthia Lummis

38,813 views • 1 year ago